Stockreport

JPM26: Leo Pharma's growth strategy puts a spotlight on rare dermatology diseases [Yahoo! Finance]

Sanofi - American Depositary Shares  (SNY) 
US:NYSE Investor Relations: sanofi.com/en/investors
PDF The CEO, Christophe Bourdon, discussed that he was there to make deals focused on assets in rare disease space within dermatology. Leo's dermatology focused portfolio [Read more]